1. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to- Moderate Ulcerative Colitis in a Randomized Controlled Trial 
Alon Lang, Nir Salomon, Justin C.Y. Wu, Uri Kopylov, Adi Lahat, Ofir Har-Noy, Jessica Y.L. Ching, Pui Kuan Cheong, Benjamin Avidan, Dorit Gamus, Ioannis Kaimakliotis, Rami Eliakim, Siew C. Ng, Shomron Ben-Horin 
Clinical Gastroenterology and Hepatology 
Volume 13, Issue 8, Pages e1 (August 2015)
DOI: /j.cgh
Copyright © 2015 AGA Institute Terms and Conditions

2. Figure 1
Clinical response and remission rate at study end point at week 4.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2015 AGA Institute Terms and Conditions

3. Figure 2
(A) Endoscopic response and remission rate at study end point at week 4. (B) Mean endoscopic rate at week 0 compared with week 4 in the 2 study groups.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2015 AGA Institute Terms and Conditions

4. Supplementary Figure 1
Flow chart of patient enrollment into the study and randomization scheme. 5ASA, mesalamine; C.diff, Clostridium difficile; ITT, intention-to-treat; PP, per-protocol.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2015 AGA Institute Terms and Conditions